⚠️ Critical Safety Warning
Psilocybin is contraindicated for certain individuals and conditions. If you have any medical conditions, take medications, or have a family history of certain conditions, consult healthcare professionals before considering psilocybin use.
Introduction to Contraindications
Psilocybin is not safe for everyone. Certain medical conditions, medications, and risk factors make psilocybin use dangerous or contraindicated. Understanding contraindications is essential for safety. Some contraindications are absolute (never use), while others require careful consideration and medical consultation.
This comprehensive guide covers contraindications: schizophrenia and psychotic disorders, certain medications (MAOIs, SSRIs), cardiovascular conditions, pregnancy and breastfeeding, age considerations, and other risk factors. Understanding contraindications helps prevent serious harm.
Safety must always be the top priority. If you have any conditions or take medications, consult healthcare professionals before considering psilocybin use. Some contraindications are absolute, while others require careful evaluation.
Schizophrenia and Psychotic Disorders
Absolute Contraindication
Psilocybin is contraindicated for:
- Schizophrenia
- Other psychotic disorders
- Family history of schizophrenia
- Can trigger or worsen psychosis
- Potentially dangerous
Certain Medications
MAOIs
MAOIs are absolute contraindication:
- Can cause serotonin syndrome
- Potentially fatal
- Never combine
SSRIs and Antidepressants
SSRIs and antidepressants:
- Can cause serotonin syndrome
- Generally contraindicated
- Consult healthcare providers
Cardiovascular Conditions
Heart Conditions
Cardiovascular conditions:
- May be contraindicated
- Can affect heart rate and blood pressure
- Consult healthcare professionals
- Consider risks carefully
Pregnancy and Breastfeeding
Pregnancy
Pregnancy considerations:
- Not recommended during pregnancy
- Unknown effects on fetus
- Safety concerns
- Generally contraindicated
Breastfeeding
Breastfeeding considerations:
- Not recommended while breastfeeding
- Unknown effects on infant
- Safety concerns
Age Considerations
Minors
Age restrictions:
- Not recommended for minors
- Brain development concerns
- Legal restrictions
- Safety considerations
Other Risk Factors
Additional Considerations
Other risk factors include:
- Severe mental health conditions
- Certain medical conditions
- Various medications
- Consult healthcare professionals
Comprehensive Medical Conditions List
Classification System
Contraindications are classified by severity:
- ABSOLUTE (❌): Never use - high risk of serious harm or death
- STRONG (⚠️): Generally should not use - significant risks present
- RELATIVE (⚡): Requires medical consultation and extreme caution
- CONDITIONAL (ℹ️): May be acceptable under medical supervision
Psychiatric and Neurological Conditions
❌ ABSOLUTE CONTRAINDICATIONS
| Condition | Reason for Contraindication | Potential Risks |
|---|---|---|
| Schizophrenia | Can trigger acute psychotic episodes, worsen existing symptoms | Psychotic break, permanent worsening, hospitalization, suicide risk |
| Schizoaffective Disorder | Combination of schizophrenia and mood symptoms | Severe psychotic episode, mood destabilization |
| First-degree family history of schizophrenia | Genetic predisposition; psychedelics may trigger latent condition | Onset of schizophrenia, early manifestation of latent condition |
| Brief Psychotic Disorder (history) | Previous psychotic break indicates vulnerability | Recurrence of psychosis, prolonged episode |
| Delusional Disorder | Fixed false beliefs; psychedelics can reinforce or worsen delusions | Strengthened delusions, loss of insight |
⚠️ STRONG CONTRAINDICATIONS - Psychiatric
| Condition | Concerns | Guidance |
|---|---|---|
| Bipolar I Disorder | Risk of triggering manic or mixed episodes | Avoid unless in stable period with psychiatrist supervision; high risk during current episode |
| Bipolar II Disorder | Can trigger hypomania or depression | Requires medical consultation; mood stabilization essential |
| Borderline Personality Disorder (severe) | Emotional dysregulation, dissociation risk, self-harm risk | High risk without therapeutic support; only with trained therapist present |
| Dissociative Identity Disorder | Can exacerbate dissociation, switching between alters | Requires specialist supervision only |
| Active Suicidal Ideation | Unpredictable emotional amplification, impaired judgment | NEVER use; seek immediate mental health help |
| Recent Suicide Attempt (within 6 months) | High vulnerability, risk of triggering crisis | Absolute avoidance; stabilization required first |
| Severe PTSD (unmanaged) | Can trigger flashbacks, retraumatization, overwhelming emotions | Only in clinical/therapeutic setting with trauma-trained provider |
⚡ RELATIVE CONTRAINDICATIONS - Psychiatric
| Condition | Considerations | Safe Use Requirements |
|---|---|---|
| Major Depressive Disorder (moderate-severe) | Can intensify emotions; potential benefit but also risk | Stable period, no suicidal ideation, sitter present, integration support |
| Generalized Anxiety Disorder (severe) | Can increase anxiety during experience | Start with very low dose, safe environment, benzodiazepine available |
| OCD (Obsessive-Compulsive Disorder) | Can temporarily worsen obsessions or create new ones | Stable management, therapeutic context preferred |
| Panic Disorder | May trigger panic attacks | Well-managed panic disorder, sitter, rescue medication available |
| Eating Disorders (active) | Body image distortions, emotional dysregulation | Stable recovery phase only, therapeutic support |
⚡ NEUROLOGICAL CONDITIONS
| Condition | Risk Level | Specific Concerns |
|---|---|---|
| Epilepsy/Seizure Disorder | ⚠️ STRONG | Psilocybin may lower seizure threshold; especially dangerous if on lithium |
| Traumatic Brain Injury (recent) | ⚠️ STRONG | Brain still healing; unpredictable effects; wait 6-12 months minimum |
| Migraine with Aura | ⚡ RELATIVE | May trigger migraine; some report benefit; proceed cautiously |
| Multiple Sclerosis | ℹ️ CONDITIONAL | Limited data; consult neurologist; may affect symptoms unpredictably |
Cardiovascular Conditions
⚠️ STRONG CONTRAINDICATIONS - Cardiovascular
| Condition | Why Contraindicated | Physiological Impact |
|---|---|---|
| Severe Coronary Artery Disease | Psilocybin increases heart rate and blood pressure | Can trigger angina, heart attack |
| Recent Heart Attack (within 6 months) | Heart still healing; increased cardiac demand dangerous | Risk of another cardiac event |
| Uncontrolled Hypertension (>160/100) | Further blood pressure elevation dangerous | Stroke risk, hypertensive crisis |
| Severe Heart Valve Disease | Increased cardiac workload problematic | Heart failure, arrhythmias |
| Recent Stroke (within 12 months) | Blood pressure changes risky during recovery | Recurrent stroke risk |
| Arrhythmias (serious) | Can destabilize heart rhythm | Dangerous arrhythmia, cardiac arrest |
⚡ RELATIVE CONTRAINDICATIONS - Cardiovascular
| Condition | Precautions Required |
|---|---|
| Controlled Hypertension | Cardiologist approval, monitor BP before/during/after, have emergency plan |
| Mild Heart Valve Issues | Cardiologist clearance, avoid high doses |
| Family History of Early Heart Disease | Cardiac screening recommended first, especially if over 40 |
Pregnancy, Breastfeeding, and Reproductive Health
❌ ABSOLUTE CONTRAINDICATIONS
| Condition | Reason | Potential Harm |
|---|---|---|
| Pregnancy (all trimesters) | Unknown effects on fetal development; crosses placental barrier | Birth defects, developmental issues, uterine contractions |
| Breastfeeding | Psilocybin metabolites pass into breast milk | Unknown effects on infant brain development |
| Trying to Conceive (active) | May become pregnant without knowing | Early pregnancy exposure risks |
Washout period if pregnancy planned: At least 1 month (conservative approach due to limited data)
Age-Related Contraindications
⚠️ Adolescents and Young Adults (Under 25)
Concerns:
- Brain Development: Prefrontal cortex not fully developed until ~25 years
- Psychosis Risk: Peak age for schizophrenia onset (late teens to mid-20s)
- Psychological Readiness: Less developed coping mechanisms
- Long-term Impact Unknown: No studies on developing brains
Recommendation: Strong discouragement; if use occurs, extreme caution with very low doses only
ℹ️ Older Adults (65+)
Special Considerations:
- Higher cardiovascular risk - screening essential
- Polypharmacy concerns - medication interactions more likely
- Mobility issues - fall risk during experience
- Cognitive changes - may affect experience/integration
- Positive note: Research shows psilocybin can be safe in healthy older adults
Requirements: Medical screening, medication review, appropriate supervision
Metabolic and Endocrine Conditions
⚡ RELATIVE CONTRAINDICATIONS
| Condition | Risk Factors | Precautions |
|---|---|---|
| Diabetes (Type 1 or 2) | May forget to eat/take insulin; stress affects blood sugar | Monitor blood glucose before/during/after; have glucose source available; sitter aware |
| Hyperthyroidism (untreated) | Increased heart rate on top of existing tachycardia | Stabilize thyroid function first |
| Severe Liver Disease | Impaired drug metabolism | Medical consultation; effects may be unpredictable/prolonged |
| Severe Kidney Disease | Altered drug clearance | Medical consultation; dose adjustment may be needed |
Immune System and Autoimmune Conditions
ℹ️ CONDITIONAL - Generally Lower Risk
Most autoimmune conditions are not direct contraindications, but consider:
| Condition | Considerations |
|---|---|
| Lupus, Rheumatoid Arthritis, MS | Check medication interactions (especially immunosuppressants); stress can trigger flares |
| HIV/AIDS | Check antiretroviral interactions; generally compatible if well-managed |
Substance Use Disorders
⚡ RELATIVE CONTRAINDICATIONS
| Condition | Concerns | Guidance |
|---|---|---|
| Active Addiction | Vulnerable mental state, may use as escape | Address active addiction first; therapeutic context only |
| Early Recovery (<6 months sober) | Fragile sobriety, potential trigger | Wait for more stable recovery; consult addiction specialist |
| History of Stimulant-Induced Psychosis | Indicates vulnerability to psychosis | High caution; consider absolute contraindication |
Exception: Some clinical trials use psilocybin for addiction treatment, but only in controlled therapeutic settings
Temporary vs Permanent Contraindications
Temporary Contraindications (Conditions that may resolve)
| Condition | Wait Time Before Reconsideration | Resolution Criteria |
|---|---|---|
| Acute Depression Episode | Until stabilized (typically 2-3 months improvement) | No suicidal ideation, functional improvement, stable for 60+ days |
| Acute Anxiety/Panic | Until managed (1-3 months) | Panic attacks controlled, coping skills developed |
| Recent Trauma | 3-6 months minimum | Initial processing begun, therapy engaged, not in acute crisis |
| Recent Surgery | 4-8 weeks | Full recovery, off pain medications, surgeon clearance |
| Pregnancy/Breastfeeding | After pregnancy/weaning complete + 1 month | No longer pregnant/nursing, hormones stabilized |
| Medication Tapering | 2-6 weeks after last dose (depends on med) | Full washout period complete, stable without meds |
Permanent Contraindications (Lifelong caution/avoidance)
- Schizophrenia/Schizoaffective Disorder: Permanent - no safe way to use
- History of Psychotic Break: Permanent high risk - avoid
- First-Degree Family History of Schizophrenia: Permanent risk factor - strong avoidance recommended
- Severe Heart Conditions: May improve but require ongoing medical clearance
- Certain Genetic Conditions: (e.g., inherited cardiac arrhythmias, certain metabolic disorders)
Medical Screening Questionnaire
Pre-Use Health Screening Tool
Answer honestly - your safety depends on it:
Part 1: Psychiatric History (HIGH PRIORITY)
Answer YES or NO to each:
- ☐ Have you ever been diagnosed with schizophrenia or schizoaffective disorder?
- ☐ Have you ever experienced psychosis (hallucinations/delusions when NOT on drugs)?
- ☐ Do you have a parent, sibling, or child with schizophrenia?
- ☐ Have you been diagnosed with bipolar I disorder?
- ☐ Are you currently having thoughts of suicide?
- ☐ Have you attempted suicide in the past 6 months?
- ☐ Are you currently in a severe depression or manic episode?
- ☐ Have you been diagnosed with severe/unstable borderline personality disorder?
If YES to ANY of the above → DO NOT USE psilocybin. Seek professional mental health support.
Part 2: Current Medications (CRITICAL)
Are you currently taking:
- ☐ MAOIs (Nardil, Parnate, Marplan, selegiline, moclobemide)?
- ☐ SSRIs (Prozac, Zoloft, Lexapro, Paxil, Celexa, Luvox)?
- ☐ SNRIs (Effexor, Cymbalta, Pristiq)?
- ☐ Lithium?
- ☐ Tramadol?
- ☐ Antipsychotics?
If YES to MAOIs or Lithium → ABSOLUTE CONTRAINDICATION.
If YES to others → Consult physician about tapering/washout or DO NOT USE.
Part 3: Cardiovascular Health
- ☐ Do you have heart disease or have you had a heart attack?
- ☐ Do you have uncontrolled high blood pressure (>140/90)?
- ☐ Do you have a history of stroke?
- ☐ Do you have serious heart rhythm problems?
- ☐ Are you over 50 with NO recent cardiac evaluation?
If YES to any → Medical evaluation required before use.
Part 4: Other Medical Conditions
- ☐ Are you pregnant, breastfeeding, or trying to conceive?
- ☐ Do you have epilepsy or a seizure disorder?
- ☐ Do you have severe liver or kidney disease?
- ☐ Have you had a recent head injury or brain surgery?
- ☐ Are you under 21 years old?
If YES to any → High caution or contraindication; medical consultation essential.
Part 5: Risk Assessment Score
Scoring:
- 0-1 YES answers (excluding Part 1): Lower risk - Proceed with standard precautions
- 2-3 YES answers: Moderate risk - Consider medical consultation, extra precautions
- 4+ YES answers: High risk - Medical supervision essential
- Any YES in Part 1: Contraindicated - Do not use
When Screening Indicates "Proceed with Caution"
Additional safety measures:
- Start with very low dose (0.5-1g dried mushrooms)
- Have experienced sitter present at all times
- Have emergency contact information immediately available
- Have "trip killer" (benzodiazepine) on hand if appropriate
- Ensure 911/emergency services accessible
- Consider professional therapeutic setting
Best Practices
- Consult healthcare professionals
- Disclose all conditions and medications
- Consider risks carefully
- When in doubt, don't use
- Prioritize safety always
Conclusion
Psilocybin is contraindicated for certain individuals and conditions. Schizophrenia, certain medications (especially MAOIs), and other conditions make psilocybin use dangerous. Understanding contraindications and consulting healthcare professionals is essential for safety.
Always consult healthcare professionals if you have medical conditions, take medications, or have concerns. Safety must always come first, and some contraindications are absolute. When in doubt, don't use psilocybin.